Live Breaking News & Updates on National Marrow Donor Program Be The

Stay updated with breaking news from National marrow donor program be the. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

National study recommends starting SARS-CoV-2

Patients with cancer whose immune systems are being supported or rebuilt by bone marrow transplantation should begin receiving vaccines for protection against SARS-CoV-2 three months post-transplant, according to a large, prospective, observational study led collaboratively by the Center for International Blood and Marrow Transplant Research, the Blood & Marrow Transplant Clinical Trials Network and Fred Hutchinson Cancer Center. The research, involving 22 cancer centers and research institutions in the United States and focusing on mRNA-based vaccines, published in The Lancet journal eClinicalMedicine. ....

United States , University Of Washington , Fred Hutch , Claire Hudson , E Donnall Thoma , Miguel Angel Perales , Joshua Hill , American Society For Transplantation , Fred Hutchinson Cancer Center , Method Of Research , International Blood , Marrow Transplant Research , National Institutes Of Health , Myeloma Research Foundation , Weil Cornell Medical College , University Of Washington School Medicine , Lymphoma Society , National Marrow Donor Program Be The , Memorial Sloan Kettering Cancer Center , Blood Marrow Transplant Clinical Trials Network , Fred Hutch Bone Marrow Transplant Program , National Cancer , Marrow Transplant Clinical Trials Network , Fred Hutchinson Cancer , Washington School , Nobel Prize ,